CMS72V14.2 STK-5 outcome evaluation with patient transfer

XMLWordPrintable

    • Type: Hosp Inpt eCQMs - Hospital Inpatient eCQMs
    • Resolution: Answered
    • Priority: Moderate
    • Component/s: None
    • None
    • Elizabeth Ballard
    • 6678955398
    • MedStar Health
    • Hide
      Thank you for your question regarding Antithrombotic Therapy by End of Hospital Day 2/STK-5 (CMS 72). The measure captures ischemic stroke patients who are administered antithrombotic therapy, starting the day of or day after hospital arrival. Not administering anti-thrombotic therapy after hospital arrival must be documented in the medical record by the Medical Doctor/Advanced Practice Nurse/Physician Assistant or pharmacist and could be mapped to an appropriate code contained in the “Medical Reason For Not Providing Treatment” value set (2.16.840.1.113883.3.117.1.7.1.473).

      Please note STK-5 is time sensitive and medication administration or a reason for not must be documented in a discrete field by the end of hospital day two.
      Show
      Thank you for your question regarding Antithrombotic Therapy by End of Hospital Day 2/STK-5 (CMS 72). The measure captures ischemic stroke patients who are administered antithrombotic therapy, starting the day of or day after hospital arrival. Not administering anti-thrombotic therapy after hospital arrival must be documented in the medical record by the Medical Doctor/Advanced Practice Nurse/Physician Assistant or pharmacist and could be mapped to an appropriate code contained in the “Medical Reason For Not Providing Treatment” value set (2.16.840.1.113883.3.117.1.7.1.473). Please note STK-5 is time sensitive and medication administration or a reason for not must be documented in a discrete field by the end of hospital day two.
    • CMS0072v14
    • Needed to assist in determining if report is evaluating specific case correctly.

      Patient was evaluated in ED for stroke and had administered ASA 300 mg suppository PR administered during the ED encounter. Patient was emergently flown to our facility for neuro ICU and thrombectomy capabilities. The ASA was administered 69 minutes prior to arrival at hospital for admission. Will documentation of the medication being administered in the EDs record meet the second hospital's report outcome of Numerator Met or should providers be guided to document rational for not prescribing medication upon transfer into neuro ICU? 

            Assignee:
            Mathematica EH eCQM Team
            Reporter:
            Elizabeth D Ballard
            Votes:
            0 Vote for this issue
            Watchers:
            4 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: